Pharma News
Mylan receives EU go-ahead to purchase Meda, with conditions
The European Commission (EC) has approved the multi-billion dollar acquisition of Swedish specialty pharmaceutical company Meda by Mylan, one of the world’s largest generics and specialty pharmaceutical companies, subject to certain conditions.
Teva to acquire US-based generics maker Anda
Israeli generics giant Teva Pharmaceutical Industries (Teva) announced on 3 August 2016 that it had entered into a definitive agreement to buy US generics business Anda from Allergan.
Amgen and Daiichi Sankyo make deal for biosimilars in Japan
US-based biologicals specialist Amgen and Japan-based Daiichi Sankyo announced on 13 July 2016 that they had made an exclusive agreement to commercialize nine biosimilars in Japan.
Teva generics being snapped up by rivals
There has been a rush on Teva Pharmaceutical Industries (Teva) generics recently, with another round of companies clambering over the pickings.
UK’s DoH says most medicines do not experience shortages
The UK’s Department of Health (DoH) has said that the ‘vast majority’ of prescriptions in the country are not subject to supply problems.
AMRI acquires API maker Euticals
US-based Albany Molecular Research Inc (AMRI) announced on 5 May 2016 that it had entered into a definitive agreement to buy Prime European Therapeuticals, also known as Euticals.
Lannett to co-develop biosimilar insulin product with Chinese partner
US generics maker Lannett Company (Lannett) announced on 22 April 2016 plans to co-develop a biosimilar insulin product for the US market with its strategic partner in China, Yichang HEC Changjiang Pharmaceutical (Yichang), which is part of the HEC Group.
Teva and Takeda establish ‘Teva Takeda Yakuhin’ in Japan
Israeli generics giant Teva Pharmaceutical Industries (Teva) and Japan-based Takeda Pharmaceutical Company (Takeda) have formed a joint company ‘Teva Takeda Yakuhin’ to produce and sell off-patented medicines in Japan.
SGS and DiscoverX to collaborate on bioassays for biosimilars
Contract solutions provider SGS announced on 30 March 2016 that it had entered into a collaboration with innovative life science company DiscoverX.
Dr Reddy’s and TRPharm collaborate on biosimilars in Turkey
Generics giant Dr Reddy’s Laboratories and Turkish pharma start-up firm TRPharm announced on 10 March 2016 that they had entered into a strategic collaboration agreement for a portfolio of biosimilars in Turkey.
